Cargando…

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

BACKGROUND: Ovarian cancer is a heterogeneous disease and prognosis for apparently similar cases of ovarian cancer varies. Recurrence of the disease in early stage (FIGO-stages I-II) serous ovarian cancer results in survival that is comparable to those with recurrent advanced-stage disease. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skirnisdottir, Ingiridur, Mayrhofer, Markus, Rydåker, Maria, Åkerud, Helena, Isaksson, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495882/ https://www.ncbi.nlm.nih.gov/pubmed/22967087 http://dx.doi.org/10.1186/1471-2407-12-407

Ejemplares similares

Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2015)

The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I–II
por: SKIRNISDOTTIR, INGIRIDUR, et al.
Publicado: (2016)

Napsin A as a marker of clear cell ovarian carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2013)

The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer
por: Bjersand, Kathrine, et al.
Publicado: (2017)

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.
por: Foulkes, W. D., et al.
Publicado: (1993)

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
por: Foulkes, W. D., et al.
Publicado: (1993)

Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
por: Englefield, P., et al.
Publicado: (1994)

Candidate target genes for loss of heterozygosity on human chromosome 17q21
por: DeMarchis, L, et al.
Publicado: (2004)

Candidate target genes for loss of heterozygosity on human chromosome 17q21
por: DeMarchis, L, et al.
Publicado: (2004)

Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
por: Ding, S. F., et al.
Publicado: (1991)

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
por: Chappell, S. A., et al.
Publicado: (1997)

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder
por: Edwards, J, et al.
Publicado: (2001)

Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.
por: Swift, A., et al.
Publicado: (1995)

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
por: Cleton-Jansen, A. M., et al.
Publicado: (1995)

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
por: Brewster, S. F., et al.
Publicado: (1994)

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas.
por: Sheng, Z. M., et al.
Publicado: (1996)

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches
por: Cleton-Jansen, A-M, et al.
Publicado: (2000)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis
por: Pan, Zhenyu, et al.
Publicado: (2017)

Frequent Loss of Heterozygosity at the MCC Locus on Chromosome 5q21‐22 in Sporadic Colorectal Carcinomas
por: Miki, Yoshio, et al.
Publicado: (1991)

Evaluation of loss of heterozygosity of chromosome 22q11.21 region in patients with congenital heart diseases
por: Behiry, Eman G., et al.
Publicado: (2018)

Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma.
por: Bethwaite, P. B., et al.
Publicado: (1995)

Different Incidence of Loss of Heterozygosity on Chromosome 16q between Intraductal Papilloma and Intracystic Papillary Carcinoma of the Breast
por: Tsuda, Hitoshi, et al.
Publicado: (1994)

Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
por: Gustafson, C. E., et al.
Publicado: (1994)

Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
por: Tavassoli, M., et al.
Publicado: (1996)

PTEN/MMAC1 Mutation and Frequent Loss of Heterozygosity Identified in Chromosome 10q in a Subset of Hepatocellular Carcinomas
por: Fujiwara, Yoshiyuki, et al.
Publicado: (2000)

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
por: Jernvall, P, et al.
Publicado: (1999)

Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma
por: Zhang, Wandong, et al.
Publicado: (1990)

Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors
por: Zhang, Zhouwei, et al.
Publicado: (2020)

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors
por: Lourenço, Nelson, et al.
Publicado: (2014)

MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome
por: Kumar, Aswathi, et al.
Publicado: (2023)

Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
por: Lee, S. H., et al.
Publicado: (1995)

Change in Methylation Status of DNA of Remaining Allele in Human Lung Cancers with Loss of Heterozygosity on Chromosomes 3p and 13q
por: Shiraishi, Masahiko, et al.
Publicado: (1989)

Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
por: Staaf, Johan, et al.
Publicado: (2008)

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
por: Lawrence, Ben, et al.
Publicado: (2018)

Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer
por: Nowacka-Zawisza, Maria, et al.
Publicado: (2015)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ft3a826vmaishlgknvfh9rv4d2